Linda L. Chang

Linda L. Chang is a seasoned executive with extensive experience in finance and operations across various organizations in the biotechnology and pharmaceutical sectors. Currently serving as the Chief Executive Officer and Chief Financial Officer of Euclid Vision Group since October 2020, Linda has held multiple senior leadership roles including Chief Financial Officer and Chief Operating Officer at Science and Medicine Group, and Chief Financial Officer at Osiris Therapeutics and Therabron Therapeutics. Prior experience includes prominent positions at PharmAthene, Inc. and Human Genome Sciences, Inc. Linda holds a Bachelor of Science in Business Administration from the University of California, Riverside, as well as a Master of Accountancy and an MBA from the University of Georgia, emphasizing a strong foundation in financial management and operational strategy.